Despite the continued success of GLP-1 drugs Ozempic and Wegovy, Novo Nordisk CEO Lars Fruergaard Jørgensen took a slight pay cut in 2024. He received 57.1 million Danish kroner (DKK) – $8 million – ...
Short-selling is an interesting part of the stock market that can be dangerous and even controversial. Investors selling ...
A lawsuit challenges the FDA's decision to remove semaglutide from the shortage list, alleging it was arbitrary and harms ...
The results showed statistically significant and clinically meaningful improvement in progression-free survival compared with ...
A child in West Texas has died of measles, state health officials said on Wednesday (February 26), the first reported U.S.